‘Time to cure’ around 6 years for young ALL patients regardless of risk status

UK researchers have a calculated a “time to cure” of around 6 years after diagnosis for children and young adults with acute lymphoblastic leukaemia (ALL), regardless of risk status. “Knowing when patients with ALL are cured will allow their timely transfer to clinics devoted to monitoring long-term morbidity rather than relapse and facilitates communication to patients and families”, say Ajay Vora (Great Ormond Street Hospital, London) and colleagues in the Journal of Clinical Oncology.
Lire >

Long COVID risk small in children

Researchers find a high burden of non-specific persistent symptoms in children aged 14 years or younger, with SARS-CoV-2 infection adding to this only slightly.
Lire >